O	O	O	0	8	Enhanced	Enhance	B-NP	VBN	O	2	NMOD	O
O	O	O	9	23	responsiveness	responsiveness	I-NP	NN	O	8	SUB	O
O	O	O	24	26	to	to	B-PP	TO	O	2	NMOD	O
T2	B-Entity	B-Entity	27	34	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD	B-protein
T2	I-Entity	I-Entity	35	41	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
T2	I-Entity	I-Entity	42	47	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
T2	I-Entity	I-Entity	48	49	B	B	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	50	61	contributes	contribute	B-VP	VBZ	O	0	ROOT	O
O	O	O	62	64	to	to	B-PP	TO	O	8	VMOD	O
O	O	O	65	68	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	69	75	unique	unique	I-NP	JJ	O	12	NMOD	O
O	O	O	76	85	phenotype	phenotype	I-NP	NN	O	9	PMOD	O
O	O	O	86	88	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	89	95	simian	simian	B-NP	JJ	O	18	NMOD	O
O	O	O	96	112	immunodeficiency	immunodeficiency	I-NP	NN	O	18	NMOD	O
O	O	O	113	118	virus	virus	I-NP	NN	O	18	NMOD	O
O	O	O	119	126	variant	variant	I-NP	JJ	O	18	NMOD	O
O	O	O	127	138	SIVsmmPBj14	SIVsmmPBj14	I-NP	NN	O	13	PMOD	O
O	O	O	138	139	.	.	O	.	O	8	P	O

O	O	O	141	150	Infection	Infection	B-NP	NN	O	12	SUB	O
O	O	O	151	155	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	156	157	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	158	165	variant	variant	I-NP	NN	O	10	NMOD	O
O	O	O	166	168	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	169	175	simian	simian	B-NP	JJ	O	8	NMOD	O
O	O	O	176	192	immunodeficiency	immunodeficiency	I-NP	NN	O	8	NMOD	O
O	O	O	193	198	virus	virus	I-NP	NN	O	5	PMOD	O
O	O	O	198	199	,	,	O	,	O	10	P	O
O	O	O	200	211	SIVsmmPBj14	SIVsmmPBj14	B-NP	NN	O	2	PMOD	O
O	O	O	211	212	,	,	O	,	O	1	P	O
O	O	O	213	218	leads	lead	B-VP	VBZ	O	0	ROOT	O
O	O	O	219	221	to	to	B-PP	TO	O	12	VMOD	O
O	O	O	222	228	severe	severe	B-NP	JJ	O	16	NMOD	O
O	O	O	229	234	acute	acute	I-NP	JJ	O	16	NMOD	O
O	O	O	235	242	disease	disease	I-NP	NN	O	13	PMOD	O
O	O	O	243	245	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	246	254	macaques	macaque	B-NP	NNS	O	17	PMOD	O
O	O	O	254	255	.	.	O	.	O	12	P	O

O	O	O	256	260	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	261	266	study	study	I-NP	NN	O	3	SUB	O
O	O	O	267	270	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	271	279	designed	design	I-VP	VBN	O	3	VC	O
O	O	O	280	282	to	to	B-VP	TO	O	6	VMOD	O
O	O	O	283	294	investigate	investigate	I-VP	VB	O	4	VMOD	O
O	O	O	295	298	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	299	309	functional	functional	I-NP	JJ	O	9	NMOD	O
O	O	O	310	322	significance	significance	I-NP	NN	O	6	OBJ	O
O	O	O	323	325	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	326	336	previously	previously	B-NP	RB	O	12	AMOD	O
O	O	O	337	346	described	describe	I-NP	VBN	O	13	NMOD	O
O	O	O	347	356	mutations	mutation	I-NP	NNS	O	10	PMOD	O
O	O	O	357	359	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	360	363	the	the	B-NP	DT	O	19	NMOD	O
T3	B-Entity	B-Entity	364	369	viral	viral	I-NP	JJ	B-DNA	19	NMOD	B-DNA
T3	I-Entity	I-Entity	370	374	long	long	I-NP	JJ	I-DNA	19	NMOD	I-DNA
T3	I-Entity	I-Entity	375	383	terminal	terminal	I-NP	JJ	I-DNA	19	NMOD	I-DNA
T3	I-Entity	I-Entity	384	390	repeat	repeat	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	391	392	(	(	O	(	O	22	DEP	O
T4	B-Entity	B-Entity	392	395	LTR	LTR	B-NP	NN	B-DNA	22	DEP	B-DNA
O	O	O	395	396	)	)	O	)	O	19	NMOD	O
O	O	O	397	400	and	and	O	CC	O	6	VMOD	O
O	O	O	401	403	to	to	B-VP	TO	O	25	VMOD	O
O	O	O	404	413	elucidate	elucidate	I-VP	VB	O	6	VMOD	O
O	O	O	414	419	their	their	B-NP	PRP$	O	27	NMOD	O
O	O	O	420	432	contribution	contribution	I-NP	NN	O	25	OBJ	O
O	O	O	433	435	to	to	B-PP	TO	O	27	NMOD	O
O	O	O	436	439	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	440	446	unique	unique	I-NP	JJ	O	31	NMOD	O
O	O	O	447	456	phenotype	phenotype	I-NP	NN	O	28	PMOD	O
O	O	O	457	459	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	460	471	SIVsmmPBj14	SIVsmmPBj14	B-NP	NN	O	32	PMOD	O
O	O	O	471	472	.	.	O	.	O	3	P	O

T5	B-Entity	B-Entity	473	476	LTR	LTR	B-NP	NN	B-DNA	4	NMOD	B-DNA
O	O	O	476	477	-	-	B-PP	HYPH	O	4	NMOD	O
O	O	O	477	485	directed	direct	B-NP	VBN	O	4	NMOD	O
O	O	O	486	499	transcription	transcription	I-NP	NN	O	5	SUB	O
O	O	O	500	503	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	504	512	measured	measure	I-VP	VBN	O	5	VC	O
O	O	O	513	515	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	516	521	using	use	B-VP	VBG	O	7	PMOD	O
T6	B-Entity	B-Entity	522	532	luciferase	luciferase	B-NP	NN	B-DNA	11	NMOD	B-DNA
T6	I-Entity	I-Entity	533	541	reporter	reporter	I-NP	NN	I-DNA	11	NMOD	I-DNA
T6	I-Entity	I-Entity	542	552	constructs	construct	I-NP	NNS	I-DNA	8	OBJ	I-DNA
O	O	O	553	557	that	that	B-NP	WDT	O	11	NMOD	O
O	O	O	558	562	were	be	B-VP	VBD	O	12	SBAR	O
O	O	O	563	574	transiently	transiently	I-VP	RB	O	13	VMOD	O
O	O	O	575	586	transfected	transfecte	I-VP	VBN	O	13	VC	O
O	O	O	587	591	into	into	B-PP	IN	O	15	VMOD	O
O	O	O	592	600	cultured	culture	B-NP	VBN	B-cell_line	18	NMOD	B-cell_line
O	O	O	601	606	cells	cell	I-NP	NNS	I-cell_line	16	PMOD	I-cell_line
O	O	O	606	607	.	.	O	.	O	5	P	O

O	O	O	608	610	In	In	B-PP	IN	O	18	VMOD	O
O	O	O	611	612	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	613	617	wide	wide	I-NP	JJ	O	4	NMOD	O
O	O	O	618	623	range	range	I-NP	NN	O	1	PMOD	O
O	O	O	624	626	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	627	631	cell	cell	B-NP	NN	O	7	NMOD	O
O	O	O	632	637	types	type	I-NP	NNS	O	5	PMOD	O
O	O	O	637	638	,	,	O	,	O	18	P	O
O	O	O	639	642	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	643	648	basal	basal	I-NP	JJ	O	12	NMOD	O
O	O	O	649	664	transcriptional	transcriptional	I-NP	JJ	O	12	NMOD	O
O	O	O	665	673	activity	activity	I-NP	NN	O	18	SUB	O
O	O	O	674	676	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	677	680	the	the	B-NP	DT	O	15	NMOD	O
T7	B-Entity	B-Entity	681	684	LTR	LTR	I-NP	NN	B-DNA	13	PMOD	B-DNA
T7	I-Entity	I-Entity	685	689	from	from	B-PP	IN	O	12	NMOD	O
T7	I-Entity	I-Entity	690	701	SIVsmmPBj14	SIVsmmPBj14	B-NP	NN	O	16	PMOD	O
O	O	O	702	705	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	706	711	found	find	I-VP	VBN	O	18	VC	O
O	O	O	712	714	to	to	I-VP	TO	O	21	VMOD	O
O	O	O	715	717	be	be	I-VP	VB	O	19	VMOD	O
O	O	O	718	719	2	2	B-NP	CD	O	21	PRD	O
O	O	O	719	720	-	-	B-ADJP	HYPH	O	22	P	O
O	O	O	721	723	to	to	B-PP	TO	O	25	AMOD	O
O	O	O	724	725	4	4	B-NP	CD	O	22	NMOD	O
O	O	O	725	726	.	.	O	.	O	18	P	O
O	O	O	726	727	5	5	B-NP	CD	O	30	AMOD	O
O	O	O	727	728	-	-	O	HYPH	O	27	P	O
O	O	O	728	732	fold	fold	B-ADJP	RB	O	27	NMOD	O
O	O	O	733	739	higher	high	I-ADJP	JJR	O	18	PRD	O
O	O	O	740	744	than	than	B-PP	IN	O	30	AMOD	O
O	O	O	745	749	that	that	B-NP	DT	O	31	PMOD	O
O	O	O	750	752	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	753	755	an	an	B-NP	DT	O	35	NMOD	O
T9	B-Entity	B-Entity	756	759	LTR	LTR	I-NP	NN	B-DNA	33	PMOD	B-DNA
T9	I-Entity	I-Entity	760	764	from	from	B-PP	IN	O	32	NMOD	O
T9	I-Entity	I-Entity	765	766	a	a	B-NP	DT	O	42	NMOD	O
T9	I-Entity	I-Entity	767	770	non	non	I-NP	AFX	B-DNA	41	AMOD	B-DNA
T9	I-Entity	I-Entity	770	771	-	-	I-NP	HYPH	O	41	AMOD	O
T9	I-Entity	I-Entity	771	778	acutely	acutely	I-NP	RB	O	41	AMOD	O
T9	I-Entity	I-Entity	779	789	pathogenic	pathogenic	I-NP	JJ	O	42	NMOD	O
T9	I-Entity	I-Entity	790	796	strain	strain	I-NP	NN	O	36	PMOD	O
O	O	O	796	797	.	.	O	.	O	18	P	O

O	O	O	798	803	These	These	B-NP	DT	O	2	NMOD	O
T11	B-Entity	B-Entity	804	808	LTRs	LTR	I-NP	NNS	B-DNA	3	SUB	B-DNA
O	O	O	809	815	differ	differ	B-VP	VBP	O	0	ROOT	O
O	O	O	816	818	by	by	B-PP	IN	O	3	VMOD	O
O	O	O	819	823	five	five	B-NP	CD	O	7	NMOD	O
O	O	O	824	829	point	point	I-NP	NN	O	7	NMOD	O
O	O	O	830	839	mutations	mutation	I-NP	NNS	O	13	NMOD	O
O	O	O	840	843	and	and	O	CC	O	13	NMOD	O
O	O	O	844	845	a	a	B-NP	DT	O	13	NMOD	O
T12	B-Entity	B-Entity	846	848	22	22	I-NP	CD	B-DNA	13	NMOD	B-DNA
T12	I-Entity	I-Entity	848	849	-	-	I-NP	HYPH	I-DNA	13	NMOD	I-DNA
T12	I-Entity	I-Entity	849	851	bp	bp	I-NP	NN	I-DNA	13	NMOD	I-DNA
T12	I-Entity	I-Entity	852	863	duplication	duplication	I-NP	NN	I-DNA	4	PMOD	I-DNA
O	O	O	864	866	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	867	878	SIVsmmPBj14	SIVsmmPBj14	B-NP	NN	O	14	PMOD	O
O	O	O	878	879	,	,	O	,	O	13	P	O
O	O	O	880	885	which	which	B-NP	WDT	O	13	NMOD	O
O	O	O	886	894	includes	include	B-VP	VBZ	O	17	SBAR	O
O	O	O	895	896	a	a	B-NP	DT	O	29	NMOD	O
T13	B-Entity	B-Entity	897	904	nuclear	nuclear	I-NP	JJ	B-DNA	29	NMOD	B-DNA
T13	I-Entity	I-Entity	905	911	factor	factor	I-NP	NN	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	912	917	kappa	kappa	I-NP	NN	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	918	919	B	B	I-NP	NN	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	920	921	(	(	O	(	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	921	923	NF	NF	B-NP	NN	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	924	929	kappa	kappa	I-NP	NN	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	930	931	B	B	I-NP	NN	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	931	932	)	)	O	)	I-DNA	29	NMOD	I-DNA
T13	I-Entity	I-Entity	933	937	site	site	B-NP	NN	I-DNA	18	OBJ	I-DNA
O	O	O	937	938	.	.	O	.	O	3	P	O

O	O	O	939	954	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD	O
O	O	O	955	966	differences	difference	I-NP	NNS	O	6	SUB	O
O	O	O	967	974	between	between	B-PP	IN	O	2	NMOD	O
O	O	O	975	980	these	these	B-NP	DT	O	5	NMOD	O
T16	B-Entity	B-Entity	981	985	LTRs	LTR	I-NP	NNS	B-DNA	3	PMOD	B-DNA
O	O	O	986	990	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	991	998	further	further	I-VP	RB	O	6	VMOD	O
O	O	O	999	1007	enhanced	enhance	I-VP	VBN	O	6	VC	O
O	O	O	1008	1010	by	by	B-PP	IN	O	8	VMOD	O
O	O	O	1011	1014	two	two	B-NP	CD	O	9	PMOD	O
O	O	O	1014	1015	-	-	B-ADJP	HYPH	O	10	P	O
O	O	O	1016	1018	to	to	B-PP	TO	O	10	NMOD	O
O	O	O	1019	1028	threefold	threefold	B-ADVP	RB	O	10	NMOD	O
O	O	O	1029	1033	upon	upon	B-PP	IN	O	8	VMOD	O
O	O	O	1034	1043	treatment	treatment	B-NP	NN	O	14	PMOD	O
O	O	O	1044	1046	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1047	1052	cells	cell	B-NP	NNS	O	16	PMOD	O
O	O	O	1053	1057	with	with	B-PP	IN	O	15	NMOD	O
O	O	O	1058	1065	phorbol	phorbol	B-NP	NN	O	20	NMOD	O
O	O	O	1066	1071	ester	ester	I-NP	NN	O	25	NMOD	O
O	O	O	1072	1074	or	or	O	CC	O	25	NMOD	O
T1	B-Protein	B-Protein	1075	1080	tumor	tumor	B-NP	NN	B-protein	25	NMOD	B-protein
T1	I-Protein	I-Protein	1081	1089	necrosis	necrosis	I-NP	NN	I-protein	25	NMOD	I-protein
T1	I-Protein	I-Protein	1090	1096	factor	factor	I-NP	NN	I-protein	25	NMOD	I-protein
T1	I-Protein	I-Protein	1097	1102	alpha	alpha	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	1103	1105	or	or	B-PP	CC	O	14	PMOD	O
O	O	O	1106	1108	by	by	B-PP	IN	O	14	PMOD	O
O	O	O	1109	1123	cotransfection	cotransfection	B-NP	NN	O	27	PMOD	O
O	O	O	1124	1128	with	with	B-PP	IN	O	28	NMOD	O
O	O	O	1129	1137	plasmids	plasmid	B-NP	NNS	B-DNA	29	PMOD	B-DNA
O	O	O	1138	1148	expressing	express	B-VP	VBG	O	30	NMOD	O
O	O	O	1149	1151	NF	NF	B-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	1152	1157	kappa	kappa	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	O	1158	1159	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	O	1160	1168	subunits	subunit	I-NP	NNS	I-protein	31	OBJ	I-protein
O	O	O	1168	1169	.	.	O	.	O	6	P	O

O	O	O	1170	1181	Mutagenesis	Mutagenesis	B-NP	NN	O	2	NMOD	O
O	O	O	1182	1189	studies	study	I-NP	NNS	O	6	NMOD	O
O	O	O	1189	1190	,	,	O	,	O	6	P	O
O	O	O	1191	1194	and	and	O	CC	O	6	NMOD	O
O	O	O	1195	1198	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	1199	1202	use	use	I-NP	NN	O	16	SUB	O
O	O	O	1203	1205	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	1206	1207	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	1208	1216	reporter	reporter	I-NP	NN	B-DNA	10	NMOD	B-DNA
O	O	O	1217	1226	construct	construct	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	O	1227	1237	containing	contain	B-VP	VBG	O	10	NMOD	O
O	O	O	1238	1240	an	an	B-NP	DT	O	14	NMOD	O
O	O	O	1241	1253	enhancerless	enhancerless	I-NP	JJ	B-DNA	14	NMOD	B-DNA
O	O	O	1254	1262	promoter	promoter	I-NP	NN	I-DNA	11	OBJ	I-DNA
O	O	O	1262	1263	,	,	O	,	O	6	P	O
O	O	O	1264	1272	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1273	1277	that	that	B-SBAR	IN	O	16	VMOD	O
O	O	O	1278	1283	these	these	B-NP	DT	O	20	NMOD	O
O	O	O	1284	1299	transcriptional	transcriptional	I-NP	JJ	O	20	NMOD	O
O	O	O	1300	1307	effects	effect	I-NP	NNS	O	21	SUB	O
O	O	O	1308	1311	are	be	B-VP	VBP	O	17	SBAR	O
O	O	O	1312	1315	due	due	B-ADJP	JJ	O	21	PRD	O
O	O	O	1316	1327	principally	principally	I-ADJP	RB	O	24	PMOD	O
O	O	O	1328	1330	to	to	B-PP	TO	O	22	AMOD	O
O	O	O	1331	1334	the	the	B-NP	DT	O	29	NMOD	O
T17	B-Entity	B-Entity	1335	1337	22	22	I-NP	CD	B-DNA	29	NMOD	B-DNA
T17	I-Entity	I-Entity	1337	1338	-	-	I-NP	HYPH	I-DNA	29	NMOD	I-DNA
T17	I-Entity	I-Entity	1338	1340	bp	bp	I-NP	NN	I-DNA	29	NMOD	I-DNA
T17	I-Entity	I-Entity	1341	1349	sequence	sequence	I-NP	NN	I-DNA	30	NMOD	I-DNA
T17	I-Entity	I-Entity	1350	1361	duplication	duplication	I-NP	NN	O	36	NMOD	O
O	O	O	1362	1365	and	and	O	CC	O	36	NMOD	O
O	O	O	1366	1369	the	the	B-NP	DT	O	36	NMOD	O
T18	B-Entity	B-Entity	1370	1372	NF	NF	I-NP	NN	B-DNA	36	NMOD	B-DNA
T18	I-Entity	I-Entity	1373	1378	kappa	kappa	I-NP	NN	I-DNA	36	NMOD	I-DNA
T18	I-Entity	I-Entity	1379	1380	B	B	I-NP	NN	I-DNA	36	NMOD	I-DNA
T18	I-Entity	I-Entity	1381	1385	site	site	I-NP	NN	I-DNA	24	PMOD	I-DNA
O	O	O	1386	1395	contained	contain	B-VP	VBN	O	36	NMOD	O
O	O	O	1396	1402	within	within	B-PP	IN	O	37	VMOD	O
O	O	O	1403	1405	it	it	B-NP	PRP	O	38	PMOD	O
O	O	O	1405	1406	.	.	O	.	O	16	P	O

O	O	O	1407	1414	Finally	Finally	B-ADVP	RB	O	13	VMOD	O
O	O	O	1414	1415	,	,	O	,	O	13	P	O
O	O	O	1416	1426	infectious	infectious	B-NP	JJ	O	5	NMOD	O
O	O	O	1427	1432	virus	virus	I-NP	NN	O	5	NMOD	O
O	O	O	1433	1439	stocks	stock	I-NP	NNS	O	13	SUB	O
O	O	O	1440	1444	that	that	B-NP	WDT	O	5	NMOD	O
O	O	O	1445	1449	were	be	B-VP	VBD	O	6	SBAR	O
O	O	O	1450	1458	isogenic	isogenic	B-ADJP	JJ	O	7	PRD	O
O	O	O	1459	1465	except	except	B-PP	IN	O	8	AMOD	O
O	O	O	1466	1469	for	for	B-PP	IN	O	9	PMOD	O
O	O	O	1470	1473	the	the	B-NP	DT	O	12	NMOD	O
T20	B-Entity	B-Entity	1474	1477	LTR	LTR	I-NP	NN	B-DNA	10	PMOD	B-DNA
O	O	O	1478	1482	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1483	1492	generated	generate	I-VP	VBN	O	13	VC	O
O	O	O	1492	1493	.	.	O	.	O	13	P	O

O	O	O	1494	1497	The	The	B-NP	DT	O	2	NMOD	O
T21	B-Entity	B-Entity	1498	1501	LTR	LTR	I-NP	NN	B-DNA	5	SUB	B-DNA
T21	I-Entity	I-Entity	1502	1506	from	from	B-PP	IN	O	2	NMOD	O
T21	I-Entity	I-Entity	1507	1518	SIVsmmPBj14	SIVsmmPBj14	B-NP	NN	O	3	PMOD	O
O	O	O	1519	1522	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1523	1528	found	find	I-VP	VBN	O	5	VC	O
O	O	O	1529	1531	to	to	I-VP	TO	O	8	VMOD	O
O	O	O	1532	1538	confer	confer	I-VP	VB	O	6	VMOD	O
O	O	O	1539	1541	an	an	B-NP	DT	O	10	NMOD	O
O	O	O	1542	1550	increase	increase	I-NP	NN	O	8	OBJ	O
O	O	O	1551	1553	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	1554	1557	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1558	1566	kinetics	kinetic	I-NP	NNS	O	11	PMOD	O
O	O	O	1567	1569	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1570	1575	virus	virus	B-NP	NN	O	16	NMOD	O
O	O	O	1576	1587	replication	replication	I-NP	NN	O	14	PMOD	O
O	O	O	1588	1590	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	1591	1599	cultured	culture	B-NP	VBN	B-cell_line	19	NMOD	B-cell_line
O	O	O	1600	1605	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	O	1605	1606	.	.	O	.	O	5	P	O

O	O	O	1607	1616	Inclusion	Inclusion	B-NP	NN	O	9	SUB	O
O	O	O	1617	1619	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1620	1624	this	this	B-NP	DT	O	4	NMOD	O
T23	B-Entity	B-Entity	1625	1628	LTR	LTR	I-NP	NN	B-DNA	2	PMOD	B-DNA
O	O	O	1629	1631	in	in	B-PP	IN	O	1	NMOD	O
O	O	O	1632	1643	recombinant	recombinant	B-NP	JJ	O	7	NMOD	O
O	O	O	1644	1648	SIVs	SIV	I-NP	NNS	O	5	PMOD	O
O	O	O	1649	1653	also	also	B-ADVP	RB	O	9	VMOD	O
O	O	O	1654	1662	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	O	1663	1665	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	1666	1667	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	1668	1671	two	two	I-NP	CD	O	10	PMOD	O
O	O	O	1671	1672	-	-	B-ADVP	HYPH	O	12	NMOD	O
O	O	O	1673	1675	to	to	B-PP	TO	O	13	AMOD	O
O	O	O	1676	1685	threefold	threefold	B-NP	JJ	O	16	NMOD	O
O	O	O	1686	1690	rise	rise	I-NP	NN	O	14	PMOD	O
O	O	O	1691	1693	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	1694	1697	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1698	1704	extent	extent	I-NP	NN	O	17	PMOD	O
O	O	O	1705	1707	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1708	1716	cellular	cellular	B-NP	JJ	O	22	NMOD	O
O	O	O	1717	1730	proliferation	proliferation	I-NP	NN	O	20	PMOD	O
O	O	O	1731	1735	that	that	B-NP	WDT	O	16	NMOD	O
O	O	O	1736	1739	was	be	B-VP	VBD	O	23	SBAR	O
O	O	O	1740	1747	induced	induce	I-VP	VBN	O	24	VC	O
O	O	O	1748	1750	in	in	B-PP	IN	O	25	VMOD	O
O	O	O	1751	1760	quiescent	quiescent	B-NP	JJ	B-cell_type	32	NMOD	B-cell_type
O	O	O	1761	1767	simian	simian	I-NP	JJ	I-cell_type	32	NMOD	I-cell_type
O	O	O	1768	1778	peripheral	peripheral	I-NP	JJ	I-cell_type	32	NMOD	I-cell_type
O	O	O	1779	1784	blood	blood	I-NP	NN	I-cell_type	32	NMOD	I-cell_type
O	O	O	1785	1796	mononuclear	mononuclear	I-NP	JJ	I-cell_type	32	NMOD	I-cell_type
O	O	O	1797	1802	cells	cell	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	O	1802	1803	.	.	O	.	O	9	P	O

O	O	O	1804	1809	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1810	1817	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	1818	1821	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	1822	1832	consistent	consistent	B-ADJP	JJ	O	3	PRD	O
O	O	O	1833	1837	with	with	B-PP	IN	O	4	AMOD	O
O	O	O	1838	1841	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1842	1852	hypothesis	hypothesis	I-NP	NN	O	5	PMOD	O
O	O	O	1853	1857	that	that	B-SBAR	IN	O	7	NMOD	O
T24	B-Entity	B-Entity	1858	1861	LTR	LTR	B-NP	NN	B-DNA	10	NMOD	B-DNA
O	O	O	1862	1871	mutations	mutation	I-NP	NNS	O	11	SUB	O
O	O	O	1872	1878	assist	assist	B-VP	VBP	O	8	SBAR	O
O	O	O	1879	1890	SIVsmmPBj14	SIVsmmPBj14	B-NP	NN	O	11	OBJ	O
O	O	O	1891	1893	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	1894	1904	responding	respond	B-VP	VBG	O	13	PMOD	O
O	O	O	1905	1916	efficiently	efficiently	B-ADVP	RB	O	14	VMOD	O
O	O	O	1917	1919	to	to	B-PP	TO	O	14	VMOD	O
O	O	O	1920	1928	cellular	cellular	B-NP	JJ	O	18	NMOD	O
O	O	O	1929	1940	stimulation	stimulation	I-NP	NN	O	16	PMOD	O
O	O	O	1941	1944	and	and	O	CC	O	11	VMOD	O
O	O	O	1945	1950	allow	allow	B-VP	VB	O	11	VMOD	O
O	O	O	1951	1953	it	it	B-NP	PRP	O	23	SUB	O
O	O	O	1954	1956	to	to	B-VP	TO	O	23	VMOD	O
O	O	O	1957	1966	replicate	replicate	I-VP	VB	O	20	VMOD	O
O	O	O	1967	1969	to	to	B-PP	TO	O	23	VMOD	O
O	O	O	1970	1974	high	high	B-NP	JJ	O	26	NMOD	O
O	O	O	1975	1981	titers	titer	I-NP	NNS	O	24	PMOD	O
O	O	O	1982	1988	during	during	B-PP	IN	O	23	VMOD	O
O	O	O	1989	1992	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	1993	1998	acute	acute	I-NP	JJ	O	30	NMOD	O
O	O	O	1999	2004	phase	phase	I-NP	NN	O	27	PMOD	O
O	O	O	2005	2007	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	2008	2013	viral	viral	B-NP	JJ	O	33	NMOD	O
O	O	O	2014	2023	infection	infection	I-NP	NN	O	31	PMOD	O
O	O	O	2023	2024	.	.	O	.	O	3	P	O
